by Eric Christianson | Dec 22, 2019 | Endocrine Medication and Disease State Clinical Pearls, Long Term Care Consultant Pharmacist Education and Information, Medication and Disease State Clinical Pearls For Pharmacists
I’ve worked within the walls of numerous types of settings that have access to life-saving and life-threatening medications. Whether it be at a clinic, long term care facility, assisted living facility, or hospital, it can be easy for staff to have a cavalier...
by Eric Christianson | Dec 11, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
Both salmeterol and formoterol are considered long-acting beta-agonists. These agents have been commonly used in the setting of asthma and COPD. Each of these agents is most commonly combined with an inhaled corticosteroid. Budesonide is coupled with formoterol in the...
by Eric Christianson | Dec 8, 2019 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
With the recent changes in the Beers Criteria, glimepiride has now been added to the list of sulfonylureas to avoid. Glipizide is the preferred agent if a sulfonylurea is to be used. This begs the question, should we recommend changing glimepiride to glipizide? In my...
by Eric Christianson | Dec 1, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
In keeping it real today, I wanted to share my top 5 medications that worsen dementia. This list is totally anecdotal based upon my experience and the frequency with which I see these medications used in clinical practice. Without further ado, here are my top 5...
by Eric Christianson | Nov 27, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I have seen the prescribing cascade happen in clinical practice far too many times! One of those classic examples is heart failure. A patient is placed on a new medication that contributes to edema and heart failure. With a period of days to weeks, that patient is...
by Eric Christianson | Nov 10, 2019 | Drug Interaction Case Studies and Education For Pharmacists, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t...
